The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 7, 2025 in West Pharmaceutical Services, Inc. Lawsuit - WST

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of West Pharmaceutical Services, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements during the class period from February 16, 2023, to February 12, 2025 [1]. Group 1: Allegations - The complaint alleges that West Pharmaceutical Services claimed strong visibility into customer demand while actually experiencing significant destocking in its high-margin HVP portfolio [1]. - The SmartDose device, positioned as a high-margin growth product, was found to be dilutive to profit margins due to operational inefficiencies [1]. - Margin pressures from these issues raised the risk of costly restructuring activities, including exiting continuous glucose monitoring contracts with longstanding customers [1]. - Positive statements made by the defendants regarding the company's business and prospects were deemed materially false or misleading [1]. Group 2: Class Action Details - Shareholders who purchased shares of WST during the specified class period are encouraged to register for the class action, with a deadline of July 7, 2025, to seek lead plaintiff status [2]. - Registered shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2]. - Participation in the case incurs no cost or obligation for shareholders [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].